GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » SR biotek Inc (XKRX:270210) » Definitions » Debt-to-Revenue

SR biotek (XKRX:270210) Debt-to-Revenue : 0.00 (As of . 20)


View and export this data going back to 2017. Start your Free Trial

What is SR biotek Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

SR biotek's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₩0.00 Mil. SR biotek's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₩0.00 Mil. SR biotek's annualized Revenue for the quarter that ended in . 20 was ₩0.00 Mil.


SR biotek Debt-to-Revenue Historical Data

The historical data trend for SR biotek's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SR biotek Debt-to-Revenue Chart

SR biotek Annual Data
Trend
Debt-to-Revenue

SR biotek Semi-Annual Data
Debt-to-Revenue

Competitive Comparison of SR biotek's Debt-to-Revenue

For the Household & Personal Products subindustry, SR biotek's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SR biotek's Debt-to-Revenue Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, SR biotek's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where SR biotek's Debt-to-Revenue falls into.



SR biotek Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

SR biotek's Debt-to-Revenue for the fiscal year that ended in . 20 is calculated as

SR biotek's annualized Debt-to-Revenue for the quarter that ended in . 20 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is one times the quarterly (. 20) Revenue data.


SR biotek Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of SR biotek's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


SR biotek Business Description

Traded in Other Exchanges
N/A
Address
Dumchon Boulevard, B101, Cox Tower, 484 City, Jungwon-gu, Gyeonggi-do, Seongnam-si, KOR, 13229
SR biotek Inc is engaged in the business of manufacturing and distribution of cosmetic products. The company's products include Raphitox and Idenel line.

SR biotek Headlines

No Headlines